<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">RSX</journal-id>
<journal-id journal-id-type="hwp">sprsx</journal-id>
<journal-id journal-id-type="nlm-ta">Reprod Sci</journal-id>
<journal-title>Reproductive Sciences</journal-title>
<issn pub-type="ppub">1933-7191</issn>
<issn pub-type="epub">1933-7205</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1933719112442245</article-id>
<article-id pub-id-type="publisher-id">10.1177_1933719112442245</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>MiR-21</italic> is Enriched in the RNA-Induced Silencing Complex and Targets <italic>COL4A1</italic> in Human Granulosa Cell Lines</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mase</surname>
<given-names>Yuri</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1933719112442245">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ishibashi</surname>
<given-names>Osamu</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-1933719112442245">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ishikawa</surname>
<given-names>Tomoko</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-1933719112442245">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takizawa</surname>
<given-names>Takami</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff2-1933719112442245">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kiguchi</surname>
<given-names>Kazushige</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff3-1933719112442245">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ohba</surname>
<given-names>Takashi</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff4-1933719112442245">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Katabuchi</surname>
<given-names>Hidetaka</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff4-1933719112442245">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takeshita</surname>
<given-names>Toshiyuki</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff1-1933719112442245">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Takizawa</surname>
<given-names>Toshihiro</given-names>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="aff2-1933719112442245">2</xref>
<xref ref-type="corresp" rid="corresp1-1933719112442245"/>
</contrib>
</contrib-group>
<aff id="aff1-1933719112442245">
<label>1</label>Department of Obstetrics and Gynecology, Nippon Medical School, Japan</aff>
<aff id="aff2-1933719112442245">
<label>2</label>Molecular Medicine and Anatomy, Nippon Medical School, Japan</aff>
<aff id="aff3-1933719112442245">
<label>3</label>Department of Obstetrics and Gynecology, St Marianna University School of Medicine, Japan</aff>
<aff id="aff4-1933719112442245">
<label>4</label>Department of Gynecology, Faculty of Medical and Pharmaceutical Sciences, Kumamoto University, Japan</aff>
<author-notes>
<corresp id="corresp1-1933719112442245">Toshihiro Takizawa, Department of Molecular Medicine and Anatomy, Nippon Medical School, 1-1-5 Sendagi, Tokyo 113-8602, Japan Email: <email>t-takizawa@nms.ac.jp</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>10</month>
<year>2012</year>
</pub-date>
<volume>19</volume>
<issue>10</issue>
<fpage>1030</fpage>
<lpage>1040</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="society">Society for Gynecologic Investigation</copyright-holder>
</permissions>
<abstract>
<p>MicroRNAs (miRNAs) are noncoding small RNAs that play important roles in a variety of physiological and pathological events. In this study, we performed large-scale profiling of EIF2C2-bound miRNAs in 3 human granulosa-derived cell lines (ie, KGN, HSOGT, and GC1a) by high-throughput sequencing and found that <italic>miR-21</italic> accounted for more than 80% of EIF2C2-bound miRNAs, suggesting that it was enriched in the RNA-induced silencing complex (RISC) and played a functional role in human granulosa cell (GC) lines. We also found high expression levels of <italic>miR-21</italic> in primary human GCs. Assuming that <italic>miR-21</italic> target mRNAs are enriched in RISC, we performed cDNA cloning of EIF2C2-bound mRNAs in KGN cells. We identified <italic>COL4A1</italic> mRNA as a <italic>miR-21</italic> target in the GC lines. These data suggest that <italic>miR-21</italic> is involved in the regulation of the synthesis of COL4A1, a component of the basement membrane surrounding the GC layer and granulosa-embedded extracellular structure.</p>
</abstract>
<kwd-group>
<kwd>microRNA</kwd>
<kwd>RNA-induced silencing complex</kwd>
<kwd>EIF2C2</kwd>
<kwd>human granulosa cell</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1933719112442245">
<title>Introduction</title>
<p>MicroRNAs (miRNAs) are noncoding RNAs (ncRNAs) of approximately 22 nucleotides (nt) in length and play a critical role in posttranscriptional regulation of numerous coding genes associated with the RNA-induced silencing complex (RISC).<sup>
<xref ref-type="bibr" rid="bibr1-1933719112442245">1</xref>,<xref ref-type="bibr" rid="bibr2-1933719112442245">2</xref>
</sup> Generally, miRNAs silence their target genes at the translational level. However, it has been shown that miRNAs degrade target gene mRNAs similar to small interfering RNAs (siRNAs).<sup>
<xref ref-type="bibr" rid="bibr3-1933719112442245">3</xref>
<xref ref-type="bibr" rid="bibr4-1933719112442245"/>–<xref ref-type="bibr" rid="bibr5-1933719112442245">5</xref>
</sup> The miRNA silencing mechanism is dependent on the complementarity between nucleotide positions 2 to 8 of the miRNAs (ie, the seed sequences) and the 3′-untranslated regions (3-UTRs) of their target genes. Recent studies have indicated that miRNAs are involved in a variety of pathological and physiological events, including cell proliferation, apoptosis, and tumorigenesis.<sup>
<xref ref-type="bibr" rid="bibr6-1933719112442245">6</xref>
<xref ref-type="bibr" rid="bibr7-1933719112442245"/>–<xref ref-type="bibr" rid="bibr8-1933719112442245">8</xref>
</sup> Recently, miRNA functions in the ovary have been also investigated. The ovarian follicle is a basic ovarian structure composed of 3 cell types, namely, a centrally located oocyte, single or multiple layers of granulosa cells (GCs), and an outer layer of theca cells.<sup>
<xref ref-type="bibr" rid="bibr9-1933719112442245">9</xref>
</sup> During ovarian follicle development, GCs and theca cells proliferate and differentiate, acquiring the ability to secrete or respond to sex hormones. Recent evidence generated in mice implicates the regulatory function of miRNAs in ovarian follicular development.<sup>
<xref ref-type="bibr" rid="bibr10-1933719112442245">10</xref>,<xref ref-type="bibr" rid="bibr11-1933719112442245">11</xref>
</sup> Other studies have identified miRNAs that are involved in steroidgenesis,<sup>
<xref ref-type="bibr" rid="bibr12-1933719112442245">12</xref>
</sup> proliferation,<sup>
<xref ref-type="bibr" rid="bibr13-1933719112442245">13</xref>,<xref ref-type="bibr" rid="bibr14-1933719112442245">14</xref>
</sup> and apoptosis.<sup>
<xref ref-type="bibr" rid="bibr13-1933719112442245">13</xref>
</sup>
</p>
<p>Despite the recent findings described above, the functions of miRNAs within GCs are not fully understood. The EIF2C2 (also designated as argonaute 2 or AGO2) is a key component of RISC and known to play a crucial role in miRNA-mediated RNA silencing pathway.<sup>
<xref ref-type="bibr" rid="bibr15-1933719112442245">15</xref>
</sup> In this study, we thus performed large-scale profiling of EIF2C2-bound miRNAs in 3 human granulosa-derived cell lines (ie, KGN, HSOGT, and GC1a) based on a high-throughput sequencing (HTS) approach. We found that <italic>miR-21</italic> was enriched in RISC in the GC lines. Furthermore, by cloning EIF2C2-bound mRNAs in KGN cells, we identified <italic>COL4A1</italic> mRNA as a <italic>miR-21</italic> target, suggesting that <italic>miR-21</italic> is involved in the regulation of the synthesis of basement membrane (BM) and/or focimatrix/Call-Exner bodies, which are characteristic structures present in GC layers in the developing follicles.</p>
</sec>
<sec id="section2-1933719112442245" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="section3-1933719112442245">
<title>Cell Culture</title>
<p>KGN,<sup>
<xref ref-type="bibr" rid="bibr16-1933719112442245">16</xref>
</sup> a human granulosa tumor–derived cell line, and human embryonic kidney 293 (HEK-293) cells were obtained from the RIKEN Bioresource Center (Tsukuba, Japan) and maintained in Dulbecco modified Eagle medium (DMEM)/Ham F12 media (Invitrogen, Carlsbad, California) supplemented with 10% fetal bovine serum (FBS) and DMEM supplemented with 10% FBS, respectively. Both GC1a<sup>
<xref ref-type="bibr" rid="bibr17-1933719112442245">17</xref>
</sup> and HSOGT,<sup>
<xref ref-type="bibr" rid="bibr18-1933719112442245">18</xref>
</sup> which are alternative human granulosa-derived cell lines, were maintained in DMEM/Ham F12 supplemented with 10% FBS. The cells were cultured at 37°C in a humidified incubator with 5% CO<sub>2</sub>.</p>
<p>Human GCs were isolated from follicular aspirates collected during oocyte retrieval from women undergoing in vitro fertilization. The samples from patients who gave informed consent were obtained according to protocols approved by the Nippon Medical School Hospital Ethics Committee.</p>
</sec>
<sec id="section4-1933719112442245">
<title>Immunoprecipitation of EIF2C2-bound RNAs</title>
<p>We examined EIF2C2-bound miRNAs and mRNAs in human GC lines. These procedures are outlined in supplement Figure S1. Immunoprecipitation (IP) of EIF2C2-bound RNAs, which contain both miRNA and target mRNA, was performed using the Human microRNA Isolation Kit Ago2 (Wako, Osaka, Japan). Cross-linking of proteins and RNAs was not carried out in the procedure of IP. Cultured human GC lines were collected and incubated in the cell lysis solution (provided with the kit) for 10 minutes at 4°C. Cell lysates were cleared by centrifugation at 20 000<italic>g</italic> for 20 minutes at 4°C. Beads conjugated to anti-human EIF2C2 antibody were added to the cell lysate and mixed by rotation for 2 hours at 4°C. The beads were then washed 3 times with cell lysis solution. EIF2C2-miRNA complexes were eluted using elution solution (provided with the kit). Elutes were phenol/chloroform extracted and subjected to ethanol precipitation to isolate EIF2C2-bound RNA.</p>
</sec>
<sec id="section5-1933719112442245">
<title>The HTS-Based miRNA Profiling</title>
<p>Total RNA was isolated from human GC lines using RNAiso reagent (Takara-Bio, Ohtsu, Japan). For total cellular miRNA HTS analysis using the Illumina Genome Analyzer II (GAII) sequencing system (Illumina, San Diego, California), small cellular RNA libraries were generated using a Small RNA Sample Prep Kit (Illumina), according to the manufacturer’s instructions. Briefly, total RNA was separated by denaturing polyacrylamide gel electrophoresis and 18- to 30-nt long RNAs were isolated. These RNAs were then ligated to 5′ and 3′ linkers. Complementary DNA (cDNA) of the small RNAs was synthesized by reverse transcription using a primer recognizing the 3′ linker. Next, polymerase chain reaction (PCR) was performed using primers recognizing the 5′ and 3′ linkers to synthesize double-stranded cDNA. For HTS analysis of EIF2C2-bound miRNAs using the Genome Sequencer (GS) FLX System (Roche, Mannheim, Germany), EIF2C2-bound miRNAs, isolated as described below, were subjected to adaptor ligation, cDNA synthesis, and PCR amplification, as described previously.<sup>
<xref ref-type="bibr" rid="bibr19-1933719112442245">19</xref>
</sup> A 3′ adaptor was ligated to the PCR products. These cDNAs were examined using a Bioanalyzer (Agilent Technologies, Santa Clara, California) and HTS on GAII or GS FLX.</p>
<p>The HTS data were subjected to bioinformatic analyses. First, adaptor sequence trimming and elimination of invalid sequences were carried out using a Paracel Filtering Package (Paracel, Inc, Pasadena, California). Second, RNA sequences (referred to as reads) above the assessment cutoff were aligned using short oligonucleotide alignment program (SOAP)<sup>
<xref ref-type="bibr" rid="bibr20-1933719112442245">20</xref>
</sup> to extract sequences matching the human genome. Finally, individual reads that were orthologous to the human genome were annotated by referring to the following databases: miRBase v13.0 (http://microrna.sanger.ac.uk/sequences/) for miRNAs, Ensembl (release53) (http://www.ensembl.org/index.html) for noncoding RNAs (except miRNAs), NCBI RefSeq (http://www.ncbi.nlm.nih.gov/RefSeq/) for RefSeq transcripts, and UCSC hg18 (http://genome.ucsc.edu/cgi-bin/hgGateway/) for genomic sequences. These databases were the latest version at the date of analyses. The HTS data obtained using GAII and GS FLX were analyzed on April 17 and 30, 2009, respectively. The majority of the remaining small RNA-derived reads corresponded to piwi-interacting RNA, ribosomal RNA, transfer RNA, small nucleolar RNA, miscellaneous RNA, and RefSeq transcripts. Sequence reads that did not correspond to any of the above databases were categorized as “only genome” (<xref ref-type="fig" rid="fig1-1933719112442245">Figure 1</xref>).</p>
<fig id="fig1-1933719112442245" position="float">
<label>Figure 1.</label>
<caption>
<p>Bioinformatic analysis of small RNA-derived reads obtained from total cellular miRNAs in human granulosa-derived KGN cells by HTS using GAII. The number of reads from categorized small RNAs are shown. HTS indicates high-throughput sequencing; GAI, Genome Analyzer II.</p>
</caption>
<graphic alternate-form-of="fig1-1933719112442245" xlink:href="10.1177_1933719112442245-fig1.tif"/>
</fig>
</sec>
<sec id="section6-1933719112442245">
<title>Complementary DNA Synthesis of EIF2C2-Bound mRNAs</title>
<p>Complementary DNA synthesis of EIF2C2-bound mRNA was performed using the Target mRNA Cloning Kit (Wako), according to the manufacturer’s protocol. Briefly, first-strand cDNA was synthesized from the EIF2C2-bound RNA fraction using oligo-dT primers and reverse transcriptase. Next, first-strand cDNAs were subjected to a second round of cDNA synthesis and subsequent PCR, using Ex Taq DNA polymerase (Takara). The PCR products were cloned using the TOPO TA Cloning Kit for Sequencing (Invitrogen) and sequenced on an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems, Foster City, California).</p>
</sec>
<sec id="section7-1933719112442245">
<title>Real-Time PCR</title>
<p>Expression of miRNA was quantified using TaqMan MicroRNA Assays (Applied Biosystems). Monitoring miRNA-derived PCR products was performed on the ABI 7300 or ABI 7900 Real-Time PCR Systems (Applied Biosystems). To quantify mRNA levels, SYBR Premix Ex Taq II (Perfect Real Tim; Takara Bio) was applied. To normalize miRNA and mRNA expression levels, <italic>RNU6-2</italic> (also known as <italic>U6</italic>) and <italic>glyceraldehyde 3-phosphate dehydrogenase (GAPDH</italic>) were used as endogenous internal controls, respectively. For quantification of the expression levels of <italic>miR-21</italic> and<italic> let-7a</italic> in the EIF2C2-bound miRNAs in KGN cells, serially diluted synthetic mimics of these miRNAs (from 15 fmol/L to 153.6 pmol/L of pre-miR-21 and pre-let-7a; Applied Biosystems) were used as standards. Human reproductive tissue total RNAs (the ovary, placenta, uterus, and testis) were purchased from Ambion (Austin, Texas).</p>
</sec>
<sec id="section8-1933719112442245">
<title>Luciferase Assays</title>
<p>To construct a reporter plasmid containing the 3′-UTR of the human <italic>COL4A1</italic> gene, we first cloned the 3′-UTR into pMIR-REPORT. Total RNA, isolated from KGN cells, was reverse transcribed to cDNA using PrimeScript reverse transcriptase (Takara Bio). The 3′-UTR of human <italic>COL4A1</italic> mRNA was then amplified from the cDNA using the following primers: 5′-TGAAGCCTGACTCAGCTAATGTCA-3′ (primer #1) and 5′-AAGGTATGCAAAGCTTACAAATTTATTAGC-3′ (primer #2). The PCR product was cloned into a pCR-BluntII-TOPO vector for sequence verification. The <italic>COL4A1</italic> 3′-UTR was then cloned into pMIR-REPORT (Applied Biosystems) via the NaeI and SpeI restriction sites. The final construct was designated pMIR-COL4A1. To construct a reporter plasmid with a mutated <italic>miR-21</italic> recognition site of human <italic>COL4A1</italic> 3′-UTR, the following 2 primers were synthesized: 5′-GATGGGCCCTCAATAGTGGCATACCAAAT-3′ (primer #3) and 5′-TGAGGGCCCATCGCTGTCTTTTTCTCCTTC-3′ (primer #4). These primers were designed to introduce ApaI restriction sites within PCR products, which generate mutation within the putative <italic>miR-21</italic> recognition site of human <italic>COL4A1</italic> 3′-UTR. The PCR amplification was carried out with primers #1 and #4 and primers #2 and #3, using pMIR-COL4A1 as a template. The PCR products were cloned into a pCR-BluntII-TOPO vector for sequence verification. These products were digested with ApaI and either SpeI or EcoRV and cloned into pMIR-REPORT via the NaeI and SpeI restriction sites. The final construct was designated pMIR-COL4A1mut (Supplement Figure 2).</p>
<p>For luciferase assays, KGN or HEK-293 cells were transfected with pMIR-COL4A1, pMIR-COL4A1mut, or pMIR-REPORT (for the control) and pRL-tk (a constitutive Renilla luciferase expression plasmid), together with pre-miR-21, pre-miR-negative control, anti-miR-21, or anti-miR-negative control, at 10 to 20 nmol/L (Applied Biosystems). At 24 to 48 hours posttransfection, the cells were processed using the Dual-Luciferase Reporter Assay System (Promega). Luminescence was detected on a TD-20/20 Luminometer (Promega).</p>
</sec>
<sec id="section9-1933719112442245">
<title>The miRNA In Silico Target Prediction</title>
<p>Putative miRNA targets were predicted using the online algorithm MicroCosm (http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/).</p>
</sec>
<sec id="section10-1933719112442245">
<title>Western Blot</title>
<p>Cell lysates were prepared as described previously,<sup>
<xref ref-type="bibr" rid="bibr21-1933719112442245">21</xref>
</sup> subjected to 12% sodium dodecyl sulfate–polyacrylamide gel electrophoresis and transferred to Sequi-blot PVDF membranes (Bio-Rad, Hercules, California). The blots were then incubated with anti-human COL4A1 antibody (LifeSpan Biosciences, Seattle, Washington), as recommended by the manufacturers. Immunodetection was performed using Immobilon Western HRP Substrate (Millipore) and an LAS-4000 lumino-image analyzer (Fujifilm, Tokyo, Japan). Densitometric analyses of the band intensities were performed using Multi Gauge software (GE healthcare, Little Chalfont, UK).</p>
</sec>
<sec id="section11-1933719112442245">
<title>Statistical Analysis</title>
<p>The data are expressed as the mean ± standard deviation. Significant differences between the control and experimental groups were assessed by 1-way analysis of variance.</p>
</sec>
</sec>
<sec id="section12-1933719112442245">
<title>Results</title>
<sec id="section13-1933719112442245">
<title>The HTS-based Profiling of Total Cellular miRNAs in Human Granulosa-Derived KGN Cells</title>
<p>Large-scale profiling of miRNA expression provides information on the abundance of individual miRNAs in specific cells or tissues. This is a key step toward understanding the physiological and/or pathological functions of these molecules.<sup>
<xref ref-type="bibr" rid="bibr22-1933719112442245">22</xref>
</sup> Thus, we conducted HTS-based profiling of total cellular miRNAs from human granulosa-derived KGN cells. By performing HTS using the GAII system, we obtained 5 439 133 reads derived from the small RNAs of KGN cells. These reads were filtered through multiple algorithms and ncRNA-derived sequences were identified, as described in the Materials and Methods. A total of 4 035 612 reads passed the final filtration step. The reads were then classified using several RNA databases (<xref ref-type="fig" rid="fig1-1933719112442245">Figure 1</xref>). Notably, 3 798 208 reads (94.1% of the ncRNA-derived reads) matched miRNA sequences registered in miRBase version 13.0. By analyzing these data, 383 miRNA genes were identified. The most abundant miRNAs (ie, greater than 0.1% of the entire miRNA population) in KGN cells are summarized in <xref ref-type="table" rid="table1-1933719112442245">Table 1</xref>.</p>
<table-wrap id="table1-1933719112442245" position="float">
<label>Table 1.</label>
<caption>
<p>Highly Expressed miRNAs in HTS-Based Profiling of Total Cellular miRNAs in KGN cells</p>
</caption>
<graphic alternate-form-of="table1-1933719112442245" xlink:href="10.1177_1933719112442245-table1.tif"/>
<table>
<thead>
<tr>
<th>miRNA</th>
<th>Read</th>
<th>Frequency (%)</th>
<th>Gene Family</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<italic>let-7a</italic>
</td>
<td>962 614</td>
<td>25.34</td>
<td>
<italic>let-7</italic> family</td>
</tr>
<tr>
<td>
<italic>let-7f</italic>
</td>
<td>558 336</td>
<td>14.70</td>
<td>
<italic>let-7</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-21</italic>
</td>
<td>357 852</td>
<td>9.42</td>
<td>
</td>
</tr>
<tr>
<td>
<italic>let-7b</italic>
</td>
<td>300 310</td>
<td>7.91</td>
<td>
<italic>let-7</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-221</italic>
</td>
<td>233 549</td>
<td>6.15</td>
<td>
<italic>miR-221</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-181a</italic>
</td>
<td>122 882</td>
<td>3.24</td>
<td>
<italic>miR-181</italic> family</td>
</tr>
<tr>
<td>
<italic>let-7c</italic>
</td>
<td>119 811</td>
<td>3.15</td>
<td>
<italic>let-7</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-103</italic>
</td>
<td>118 343</td>
<td>3.12</td>
<td>
<italic>miR-103</italic> family</td>
</tr>
<tr>
<td>
<italic>let-7i</italic>
</td>
<td>105 626</td>
<td>2.78</td>
<td>
<italic>let-7</italic> family</td>
</tr>
<tr>
<td>
<italic>let-7e</italic>
</td>
<td>97 452</td>
<td>2.57</td>
<td>
<italic>let-7</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-181b</italic>
</td>
<td>77 923</td>
<td>2.05</td>
<td>
<italic>miR-181</italic> family</td>
</tr>
<tr>
<td>
<italic>let-7d</italic>
</td>
<td>76 869</td>
<td>2.02</td>
<td>
<italic>let-7</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-320a</italic>
</td>
<td>70 948</td>
<td>1.87</td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-222</italic>
</td>
<td>56 641</td>
<td>1.49</td>
<td>
<italic>miR-221</italic> family</td>
</tr>
<tr>
<td>
<italic>let-7g</italic>
</td>
<td>53 339</td>
<td>1.40</td>
<td>
<italic>let-7</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-103//miR-107</italic>
</td>
<td>43 923</td>
<td>1.16</td>
<td>
<italic>miR-103</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-29a</italic>
</td>
<td>34 527</td>
<td>0.91</td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-30a</italic>
</td>
<td>30 846</td>
<td>0.81</td>
<td>
<italic>miR-30</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-25</italic>
</td>
<td>23 787</td>
<td>0.63</td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-100</italic>
</td>
<td>21 605</td>
<td>0.57</td>
<td>
<italic>miR-99</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-140-3p</italic>
</td>
<td>16 982</td>
<td>0.45</td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-99b</italic>
</td>
<td>16 050</td>
<td>0.42</td>
<td>
<italic>miR-99</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-23a</italic>
</td>
<td>15 599</td>
<td>0.41</td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-24</italic>
</td>
<td>15 572</td>
<td>0.41</td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-191</italic>
</td>
<td>15 564</td>
<td>0.41</td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-423-5p</italic>
</td>
<td>14 979</td>
<td>0.39</td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-125b</italic>
</td>
<td>11 314</td>
<td>0.30</td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-107</italic>
</td>
<td>9840</td>
<td>0.26</td>
<td>
<italic>miR-103</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-99a</italic>
</td>
<td>8931</td>
<td>0.24</td>
<td>
<italic>miR-99</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-26a</italic>
</td>
<td>7261</td>
<td>0.19</td>
<td>
</td>
</tr>
<tr>
<td>
<italic>miR-30d</italic>
</td>
<td>5270</td>
<td>0.14</td>
<td>
<italic>miR-30</italic> family</td>
</tr>
<tr>
<td>
<italic>miR-101</italic>
</td>
<td>5165</td>
<td>0.14</td>
<td>
</td>
</tr>
<tr>
<td>others</td>
<td>186 093</td>
<td>4.96</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1933719112442245">
<p>Abbreviations: miRNA, microRNAs; HTS, high-throughput sequencing.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section14-1933719112442245">
<title>Expression of miRNAs Sequenced From KGN Cells in Human GCs</title>
<p>To demonstrate that miRNAs accounted for a large fraction of the entire reads from total cellular miRNAs (<xref ref-type="table" rid="table1-1933719112442245">Table 1</xref>) are indeed expressed at high levels in human primary GCs as well as in human granulosa-derived cell lines, the expression levels of 6 miRNAs (ie, <italic>let-7f</italic>,<italic> miR-21</italic>,<italic> miR-25</italic>, <italic>miR-26a</italic>, <italic>miR-101</italic>, and <italic>miR-181a</italic>) as representatives were quantified by real-time PCR. For comparison, expression of these miRNAs in representative reproductive organs (the ovary, placenta, uterus, and testis) was also analyzed. As shown in <xref ref-type="fig" rid="fig2-1933719112442245">Figure 2A</xref>, <italic>let-7f</italic>,<italic> miR-21</italic>,<italic> miR-25</italic>, and <italic>miR-181a</italic> were predominantly expressed in the ovary as compared to the placenta, uterus, or testis. These miRNAs were found to be expressed at a considerable level in human primary GCs (n = 3), as well as in the GC lines. Alternatively, some abundant miRNAs, such as <italic>miR-26a</italic> and <italic>miR-101</italic>, were more predominantly expressed in the ovary (<xref ref-type="fig" rid="fig2-1933719112442245">Figure 2B</xref>).</p>
<fig id="fig2-1933719112442245" position="float">
<label>Figure 2.</label>
<caption>
<p>Expression levels of miRNAs that accounted for a large fraction of the entire reads from total cellular miRNAs of KGN cells in representative reproductive organs. Six abundant miRNAs (ie, <italic>let-7f</italic>,<italic> miR-21</italic>,<italic> miR-25</italic>, <italic>miR-26a</italic>, <italic>miR-101</italic>, and <italic>miR-181a</italic>) were examined by real-time PCR. Some miRNAs exhibited dominant expression in human GC lines and primary GCs (n = 3) (A), while others were more abundantly expressed in the ovary (B). The expression level of each miRNA was normalized to that of <italic>RNU6-2</italic>. Data are indicated as the mean ± SD of triplicates. miRNA indicates microRNA; PCR, polymerase chain reaction; GC, granulosa cell.</p>
</caption>
<graphic alternate-form-of="fig2-1933719112442245" xlink:href="10.1177_1933719112442245-fig2.tif"/>
</fig>
</sec>
<sec id="section15-1933719112442245">
<title>The HTS-Based Profiling of EIF2C2-bound miRNAs in Human Granulosa–Derived Cell Lines</title>
<p>Mature miRNAs associate with RISC, where they interact with EIF2C2 to induce RNA interference.<sup>
<xref ref-type="bibr" rid="bibr4-1933719112442245">4</xref>,<xref ref-type="bibr" rid="bibr5-1933719112442245">5</xref>
</sup> Thus, we performed HTS-based profiling of EIF2C2-bound miRNAs. We obtained 86 604, 87 886, and 57 610 sequence reads from KGN, HSOGT, and GC1a cells, respectively. These reads were filtered through multiple algorithms to identify ncRNA-derived sequences, as described in the Materials and Methods. Reads that passed the final filtration step were numbered as 85 751, 86 996, and 56 981 from KGN, HSOGT, and GC1a cells, respectively. The reads were then classified by referring to several RNA databases (<xref ref-type="fig" rid="fig3-1933719112442245">Figure 3</xref>). Notably, 85 458, 86 824, and 56 699 reads from KGN, HSOGT, and GC1a cells (99.7%, 99.8%, and 99.5% of the ncRNA-derived reads, respectively) matched miRNA sequences registered in miRBase version 13.0. The numbers of miRNA genes identified from KGN, HSOGT, and GC1a cells were 120, 151, and 154, respectively. <xref ref-type="table" rid="table2-1933719112442245">Table 2</xref> lists miRNAs accounting for a large fraction (more than 0.1%) of the reads from each cell line.</p>
<fig id="fig3-1933719112442245" position="float">
<label>Figure 3.</label>
<caption>
<p>Bioinformatic analysis of small RNA-derived reads obtained from EIF2C2-bound miRNAs in human granulosa–derived KGN, HSOGT, and GC1a cells by HTS using GS FLX. The number of reads from categorized small RNAs is shown. miRNA indicates microRNA; HTS, high-throughput sequencing; GS, genome sequencer.</p>
</caption>
<graphic alternate-form-of="fig3-1933719112442245" xlink:href="10.1177_1933719112442245-fig3.tif"/>
</fig>
<table-wrap id="table2-1933719112442245" position="float">
<label>Table 2.</label>
<caption>
<p>The HTS-Based Profiling of EIF2C2-Bound miRNAs in GC Lines</p>
</caption>
<graphic alternate-form-of="table2-1933719112442245" xlink:href="10.1177_1933719112442245-table2.tif"/>
<table>
<thead>
<tr>
<th colspan="3">       KGN</th>
<th colspan="3">HSOGT</th>
<th colspan="3">GC1a</th>
</tr>
<tr>
<th>miRNA</th>
<th>Read</th>
<th>Frequency (%)</th>
<th>miRNA</th>
<th>Read</th>
<th>Frequency (%)</th>
<th>miRNA</th>
<th>Read</th>
<th>Frequency (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<italic>miR-21</italic>
</td>
<td>74 129</td>
<td>86.74 </td>
<td>
<italic>miR-21</italic>
</td>
<td>69738</td>
<td>80.32</td>
<td>
<italic>miR-21</italic>
</td>
<td>47899</td>
<td>84.48</td>
</tr>
<tr>
<td>
<italic>let-7a</italic>
</td>
<td>4007</td>
<td>4.69 </td>
<td>
<italic>miR-30c</italic>
</td>
<td>3254</td>
<td>3.75</td>
<td>
<italic>let-7a</italic>
</td>
<td>1460</td>
<td>2.58 </td>
</tr>
<tr>
<td>
<italic>let-7b</italic>
</td>
<td>1436</td>
<td>1.68 </td>
<td>
<italic>miR-200c</italic>
</td>
<td>1896</td>
<td>2.18</td>
<td>
<italic>let-7f</italic>
</td>
<td>1089</td>
<td>1.92 </td>
</tr>
<tr>
<td>
<italic>miR-125b</italic>
</td>
<td>1403</td>
<td>1.64 </td>
<td>
<italic>let-7f</italic>
</td>
<td>1861</td>
<td>2.14</td>
<td>
<italic>miR-221</italic>
</td>
<td>744</td>
<td>1.31 </td>
</tr>
<tr>
<td>
<italic>let-7f</italic>
</td>
<td>1016</td>
<td>1.19 </td>
<td>
<italic>let-7a</italic>
</td>
<td>1344</td>
<td>1.55</td>
<td>
<italic>miR-30c</italic>
</td>
<td>666</td>
<td>1.17 </td>
</tr>
<tr>
<td>
<italic>miR-221</italic>
</td>
<td>596</td>
<td>0.70 </td>
<td>
<italic>miR-221</italic>
</td>
<td>1214</td>
<td>1.40</td>
<td>
<italic>let-7d</italic>
</td>
<td>612</td>
<td>1.08 </td>
</tr>
<tr>
<td>
<italic>let-7c</italic>
</td>
<td>526</td>
<td>0.62 </td>
<td>
<italic>miR-18a</italic>
</td>
<td>809</td>
<td>0.93</td>
<td>
<italic>let-7b</italic>
</td>
<td>498</td>
<td>0.88 </td>
</tr>
<tr>
<td>
<italic>miR-30c</italic>
</td>
<td>248</td>
<td>0.29 </td>
<td>
<italic>let-7d</italic>
</td>
<td>627</td>
<td>0.72</td>
<td>
<italic>miR-337-3p</italic>
</td>
<td>230</td>
<td>0.41 </td>
</tr>
<tr>
<td>
<italic>let-7d</italic>
</td>
<td>243</td>
<td>0.28 </td>
<td>
<italic>let-7b</italic>
</td>
<td>584</td>
<td>0.67</td>
<td>
<italic>miR-125b</italic>
</td>
<td>229</td>
<td>0.40 </td>
</tr>
<tr>
<td>
<italic>miR-320a</italic>
</td>
<td>165</td>
<td>0.19 </td>
<td>
<italic>miR-30b</italic>
</td>
<td>535</td>
<td>0.62</td>
<td>
<italic>miR-15b</italic>
</td>
<td>224</td>
<td>0.40 </td>
</tr>
<tr>
<td>
<italic>miR-30b</italic>
</td>
<td>153</td>
<td>0.18 </td>
<td>
<italic>miR-200b</italic>
</td>
<td>277</td>
<td>0.32</td>
<td>
<italic>let-7d</italic>
<sup>*</sup>
</td>
<td>190</td>
<td>0.34 </td>
</tr>
<tr>
<td>
<italic>let-7i</italic>
</td>
<td>135</td>
<td>0.16 </td>
<td>
<italic>miR-10a</italic>
</td>
<td>260</td>
<td>0.30</td>
<td>
<italic>miR-320a</italic>
</td>
<td>186</td>
<td>0.33 </td>
</tr>
<tr>
<td>
<italic>miR-23a</italic>
</td>
<td>116</td>
<td>0.14 </td>
<td>
<italic>miR-320a</italic>
</td>
<td>255</td>
<td>0.29</td>
<td>
<italic>miR-224</italic>
</td>
<td>180</td>
<td>0.32 </td>
</tr>
<tr>
<td>
<italic>let-7e</italic>
</td>
<td>111</td>
<td>0.13 </td>
<td>
<italic>miR-20a</italic>
</td>
<td>249</td>
<td>0.29</td>
<td>
<italic>miR-30b</italic>
</td>
<td>162</td>
<td>0.29 </td>
</tr>
<tr>
<td>others</td>
<td>1174</td>
<td>1.37</td>
<td>
<italic>miR-17</italic>
</td>
<td>229</td>
<td>0.26</td>
<td>
<italic>miR-93</italic>
</td>
<td>152</td>
<td>0.27 </td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-23a</italic>
</td>
<td>226</td>
<td>0.26</td>
<td>
<italic>miR-130a</italic>
</td>
<td>107</td>
<td>0.19 </td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-98</italic>
</td>
<td>187</td>
<td>0.22</td>
<td>
<italic>miR-17</italic>
</td>
<td>98</td>
<td>0.17 </td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-92a</italic>
</td>
<td>160</td>
<td>0.18</td>
<td>
<italic>miR-23a</italic>
</td>
<td>80</td>
<td>0.14 </td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-200a</italic>
</td>
<td>125</td>
<td>0.14 </td>
<td>
<italic>miR-335</italic>
</td>
<td>78</td>
<td>0.14 </td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-31*</italic>
</td>
<td>118</td>
<td>0.14</td>
<td>
<italic>miR-455-3p</italic>
</td>
<td>69</td>
<td>0.12 </td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-15b</italic>
</td>
<td>106</td>
<td>0.12</td>
<td>
<italic>miR-106b</italic>
<sup>*</sup>
</td>
<td>64</td>
<td>0.11 </td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-224</italic>
</td>
<td>106</td>
<td>0.12</td>
<td>
<italic>miR-222</italic>
</td>
<td>62</td>
<td>0.11 </td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-31</italic>
</td>
<td>103</td>
<td>0.12</td>
<td>
<italic>miR-424</italic>
<sup>*</sup>
</td>
<td>61</td>
<td>0.11 </td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-222</italic>
</td>
<td>101</td>
<td>0.12</td>
<td>
<italic>miR-31</italic>
<sup>*</sup>
</td>
<td>57</td>
<td>0.10 </td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-151-5p</italic>
</td>
<td>100</td>
<td>0.12</td>
<td>Others</td>
<td>1502</td>
<td>2.65</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-196b</italic>
</td>
<td>99</td>
<td>0.11 </td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>let-7g</italic>
</td>
<td>98</td>
<td>0.11 </td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-93</italic>
</td>
<td>98</td>
<td>0.11 </td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>
<italic>miR-30a</italic>
</td>
<td>92</td>
<td>0.11 </td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
<tr>
<td>
</td>
<td>
</td>
<td>
</td>
<td>others</td>
<td>1973</td>
<td>2.27</td>
<td>
</td>
<td>
</td>
<td>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-1933719112442245">
<p>Abbreviations: miRNA, microRNA; HTS, high-throughput sequencing; GS, genome sequencer.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section16-1933719112442245">
<title>Validation in miR-21 Enrichment in the RISC of KGN Cells</title>
<p>We demonstrated that <italic>miR-21 </italic>accounted for more than 80% of the EIF2C2-bound miRNA reads in the GC lines (<xref ref-type="table" rid="table2-1933719112442245">Table 2</xref>), but only 9.42% of the total cellular miRNA reads in KGN cells (<xref ref-type="table" rid="table1-1933719112442245">Table 1</xref>). Conversely,<italic> let-7a</italic> accounted for the largest fraction (25.34%) of the total cellular miRNA reads in KGN cells (<xref ref-type="table" rid="table1-1933719112442245">Table 1</xref>), but only 4.69%, 1.55%, and 2.58% of the EIF2C2-bound miRNA reads in KGN, HSOGT, and GC1a cells, respectively (<xref ref-type="table" rid="table2-1933719112442245">Table 2</xref>). These data suggest that <italic>miR-21</italic> selectively associates with RISC in human GCs when compared with other miRNAs. To corroborate this result, we absolutely quantified <italic>miR-21</italic>and<italic> let-7a</italic> in EIF2C2-bound miRNAs using synthetic miRNA mimics as standards. Consistent with the HTS profiling, the <italic>miR-21</italic> concentration was 4-fold higher in the EIF2C2-bound miRNAs in KGN cells than <italic>let-7a</italic>, suggesting that <italic>miR-21</italic> was selectively enriched in RISC (<xref ref-type="fig" rid="fig4-1933719112442245">Figure 4</xref>).</p>
<fig id="fig4-1933719112442245" position="float">
<label>Figure 4.</label>
<caption>
<p>Quantification of <italic>miR-21</italic> and <italic>let-7a</italic> in EIF2C2-bound miRNAs in human granulosa–derived KGN cells by real-time PCR. For absolute quantification, serially diluted miRNA mimics (Pre-miR-21 and Pre-let-7a) at known concentrations were analyzed in parallel. The amount of <italic>miR-21</italic> was set at 1. Data are indicated as the mean ± SD of triplicates. PCR indicates polymerase chain reaction.</p>
</caption>
<graphic alternate-form-of="fig4-1933719112442245" xlink:href="10.1177_1933719112442245-fig4.tif"/>
</fig>
</sec>
<sec id="section17-1933719112442245">
<title>The MiR-21 Target Identification in KGN Cells</title>
<p>The miRNAs and their target mRNAs are believed to co-localize to RISC, facilitating posttranscriptional gene regulation. The majority of EIF2C2-bound miRNAs were occupied by <italic>miR-21</italic> (<xref ref-type="table" rid="table2-1933719112442245">Table 2</xref>). Thus, a large fraction of EIF2C2-bound mRNAs should be targets of <italic>miR-21</italic> in KGN cells. From the EIF2C2-bound mRNA cDNA libraries, 183 colonies were isolated and harvested for plasmids prior to sequencing. Of these clones, 42 matched the sequences of registered mRNAs in the NCBI database (<xref ref-type="table" rid="table3-1933719112442245">Table 3</xref>). Although most of the genes were identified as single matches, 3 genes (<italic>COL4A1</italic>, <italic>NASP</italic>, and <italic>RN18S1</italic>) were identified as double hits (<xref ref-type="table" rid="table3-1933719112442245">Table 3</xref>). Interestingly, <italic>COL4A1</italic> was predicted in silico to be a <italic>miR-21</italic> target based on the prediction algorithm, MicroCosm. Thus, we hypothesized that <italic>COL4A1</italic> could be a <italic>miR-21</italic> target.</p>
<table-wrap id="table3-1933719112442245" position="float">
<label>Table 3.</label>
<caption>
<p>Candidates for the Targets of <italic>miR-21</italic> Based on the cDNA Cloning of EIF2C2-Bound mRNAs in KGN Cells</p>
</caption>
<graphic alternate-form-of="table3-1933719112442245" xlink:href="10.1177_1933719112442245-table3.tif"/>
<table>
<thead>
<tr>
<th>Gene Symbol</th>
<th>Description</th>
<th>Copy Numbers of Cloned mRNAs</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<italic>COL4A1</italic>
</td>
<td>Collagen, type IV, alpha 1, mRNA</td>
<td>2</td>
</tr>
<tr>
<td>
<italic>NASP</italic>
</td>
<td>Nuclear autoantigenic sperm protein (histone-binding) (NASP) transcript variant 2 or 3, mRNA</td>
<td>2</td>
</tr>
<tr>
<td>
<italic>RN18S1</italic>
</td>
<td>18 S ribosomal 1 (RN18S1), ribosomal RNA</td>
<td>2</td>
</tr>
<tr>
<td>
<italic>SERTAD2</italic>
</td>
<td>SERTA domain containing 2, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>RSRC2</italic>
</td>
<td>Arginine-/serine-rich coiled coil 2 (RSRC2), transcript variant 1, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>VIM</italic>
</td>
<td>Vimentin, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>RCN1</italic>
</td>
<td>Reticulocalbin 1, EF-hand calcium-binding domain, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>DDX20</italic>
</td>
<td>DEAD (Asp-Glu-Ala-Asp) box polypeptide 20, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>LOC100288807</italic>
</td>
<td>Similar to putative WBSCR19-like protein 7</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>BBX</italic>
</td>
<td>Bobby sox homolog (Drosophila), transcript variant 1 or 2, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>MITD1</italic>
</td>
<td>MIT, microtubule interacting and transcript, domain containing 1, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>FAM59B</italic>
</td>
<td>Family with sequence similarity 59, member B, miscRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>HNRNPH1</italic>
</td>
<td>Heterogeneous nuclear ribonucleoprotein H1 (H), mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>H3F3B</italic>
</td>
<td>H3 histone, family 3B, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>PALLD</italic>
</td>
<td>Palladin, cytoskeletal-associated protein, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>SEMA3D</italic>
</td>
<td>Sema domain, immunogloburin domain (Ig), short basic domain, secreted (semaphorin) 3D, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>MMP2</italic>
</td>
<td>Matrix metallopeptidase 2 (gelatinase A, 72 kDa gelatinase, 72 kDa type IV collagenase) (MMP2) transcript variant 1 or 2, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>RPL13A</italic>
</td>
<td>Ribosomal protein L13a, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>COL4A2</italic>
</td>
<td>Collagen type IV, alpha 2, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>USP8</italic>
</td>
<td>Ubiquitin specific peptide 8, transcript variant 1, 2, or 3, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>SPOP</italic>
</td>
<td>Speckle-type POZ protein, transcript variant 1, 2, 3, 4, 5, or 6 mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>FGFR1</italic>
</td>
<td>Fibroblast growth factor receptor 1, transcript variant 9, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>NDUFB2</italic>
</td>
<td>NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2.8 kDa, nuclear gene encoding mitochondrial protein, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>MGST3</italic>
</td>
<td>Microsomal glutathione S-transferase 3, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>RPL23</italic>
</td>
<td>Ribosomal protein L23, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>SLTM</italic>
</td>
<td>SAFB-like transcription modulator, transcript variant 1or 2</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>AGRN</italic>
</td>
<td>Agrin, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>TUBB2C</italic>
</td>
<td>Tublin, beta 2c, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>CALM2</italic>
</td>
<td>Calmodulin 2 (phosphorylase kinase, delta), mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>CF1</italic>
</td>
<td>Complement factor 1, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>CHCHD2</italic>
</td>
<td>Coiled-coil-helix-coiled-coil-helix domain containg 2, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>CRYZ</italic>
</td>
<td>Crystallin, zeta (quinone redutase), transcript variant 1, 2, 3, or 4</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>ATP13A3</italic>
</td>
<td>ATPase type 13A3, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>LAPTM4A</italic>
</td>
<td>Lysosomal protein transmembrane 4 alpha, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>HLA-C</italic>
</td>
<td>Homo sapiens major histocompatibility complex, class I, C, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>EIP1</italic>
</td>
<td>Eukaryotic translation initiation factor 1, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>DAP</italic>
</td>
<td>Death-associated protein, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>UBC</italic>
</td>
<td>Ubiquitin C, mRNA</td>
<td>1</td>
</tr>
<tr>
<td>
<italic>FEN1</italic>
</td>
<td>Flap structure-specific endonuclease 1, mRNA</td>
<td>1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-1933719112442245">
<p>Abbreviation: mRNA, messenger RNA; Ig, immunoglobulin.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section18-1933719112442245">
<title>Validation of COL4A1 as a miR-21 Target</title>
<p>To examine whether <italic>COL4A1</italic> is a direct <italic>miR-21</italic> target, we performed a luciferase assay. As shown in <xref ref-type="fig" rid="fig5-1933719112442245">Figure 5A</xref>, <italic>miR-21</italic> overexpression (successful overexpression was confirmed by real-time PCR, as shown in supplement Figure S3A) decreased luciferase activity in KGN cells cotransfected with pMIR-COL4A1 by approximately 40% when compared with the negative control, but not significantly in those cotransfected with pMIR-REPORT, a control reporter plasmid lacking the 3′-UTR, or pMIR-COL4A1mut, a reporter plasmid with mutation in the putative <italic>miR-21</italic> recognition site of human <italic>COL4A1</italic> 3′-UTR. A similar result was obtained when HEK-293 cells were used for the assay (supplement Figure S4). We also examined the effect of<italic> miR-21</italic> inhibition on <italic>COL4A1</italic> 3′-UTR-dependent luciferase activity. As shown in <xref ref-type="fig" rid="fig5-1933719112442245">Figure 5B</xref>, <italic>miR-21</italic> inhibition significantly increased luciferase activity in KGN cells cotransfected with pMIR-COL4A1 (approximately 50% compared with the inhibitor transfection), but not in pMIR-REPORT-transfected cells. Real-time PCR analysis revealed that anti-miR-21 transfection decreased detectable <italic>miR-21</italic> levels in pMIR-COL4A1-transfected cells by approximately 50% compared with that of the inhibitor control (supplement Figure S3B).</p>
<fig id="fig5-1933719112442245" position="float">
<label>Figure 5.</label>
<caption>
<p>
<italic>COL4A1</italic> silencing by <italic>miR-21</italic>. A, Target validation of <italic>miR-21</italic> using a luciferase assay of KGN cells transfected with Pre-miR-21 or NC at 20 nmol/L. Luciferase activities normalized for Renilla luciferase activities in pMIR-COL4A1-, pMIR-COL4A1mut-, and pMIR-REPORT-transfected cells are shown. B, Target validation of <italic>miR-21</italic> using the luciferase assay of KGN cells transfected with anti-miR-21 or Inh-C at 20 nmol/L. Luciferase activities normalized for Renilla luciferase activities in pMIR-REPORT- and pMIR-COL4A1-transfected cells are shown. C, <italic>COL4A1</italic> expression levels at the mRNA levels are downregulated and upregulated significantly by pre-miR-21 and anti-miR-21 transfection into human GC lines (KGN, GC1a, and HSOGT), respectively. For quantitative comparison at the mRNA level, the expression level of <italic>COL4A1</italic> was normalized to <italic>GAPDH</italic>. The averaged value of the normalized <italic>COL4A1</italic> expression in the control cells was set to 1. D, Expression levels of COL4A1 at the protein levels are also downregulated and upregulated significantly by pre-miR-21 and anti-miR-21 transfection into KGN cells, respectively. For quantitative comparison at the protein level, the intensity of each band was densitometrically determined. The intensities of COL4A1 bands were normalized to those of ACTB. Data are indicated as the mean ± SD of triplicates. *<italic>P </italic>&lt; .05. NS indicates not significant; NC, negative control; Inh-C, inhibitor control; mRNA, messenger RNA; SD, standard deviation; <italic>GAPDH</italic>, <italic>glyceraldehyde 3-phosphate dehydrogenase</italic>; ACTB, actin, beta.</p>
</caption>
<graphic alternate-form-of="fig5-1933719112442245" xlink:href="10.1177_1933719112442245-fig5.tif"/>
</fig>
<p>We next examined the mRNA levels of <italic>COL4A1</italic> in the 3 GC lines with <italic>miR-21</italic> overexpression or inhibition and showed that <italic>COL4A1</italic> expression was regulated by <italic>miR-21</italic> (<xref ref-type="fig" rid="fig5-1933719112442245">Figure 5C</xref>). Although these effects are rather weak, the effect of Pre-miR-21 in KGN cells is stronger at 50 nmol/L than at 20 nmol/L; thus, there seems to be a dose response (supplement Figure 5). In addition, as shown in <xref ref-type="fig" rid="fig5-1933719112442245">Figure 5D</xref>, COL4A1 protein levels were also decreased and increased by <italic>miR-21</italic> overexpression and inhibition, respectively. Taken together, these results demonstrate that <italic>COL4A1</italic> is a target of<italic> miR-21</italic> in KGN cells.</p>
</sec>
</sec>
<sec id="section19-1933719112442245">
<title>Discussion</title>
<p>Generating miRNA expression profiles in human GC lines is a prerequisite for a better understanding of their physiological and pathological roles. In this study, we profiled total cellular miRNAs and EIF2C2-bound miRNAs by HTS-based large-scale sequencing in human GC lines and found that <italic>miR-21</italic> was selectively enriched in RISC. Furthermore, we experimentally identified <italic>COL4A1</italic> as a <italic>miR-21 </italic>target by cDNA cloning of EIF2C2-bound mRNAs and subsequent validation.</p>
<p>The overall physiological function of miRNAs was demonstrated in the ovary of <italic>Dicer1</italic> conditional knockout mice, in which <italic>Dicer1</italic> was specifically deleted in follicular GCs.<sup>
<xref ref-type="bibr" rid="bibr23-1933719112442245">23</xref>
<xref ref-type="bibr" rid="bibr24-1933719112442245"/>
<xref ref-type="bibr" rid="bibr25-1933719112442245"/>–<xref ref-type="bibr" rid="bibr26-1933719112442245">26</xref>
</sup> These mice exhibited reduced ovulation rates, increased GC apoptosis, and were infertile. In addition, the involvement of individual miRNAs in follicle function has been recently reported. Regarding <italic>miR-21</italic>, there are several reports indicating important roles of this miRNA in GCs. <italic>MiR-21</italic> was shown to rapidly increase following in vivo luteinizing hormone/human chorionic gonadotropin administration.<sup>
<xref ref-type="bibr" rid="bibr27-1933719112442245">27</xref>
</sup> Consistent with the findings in a number of other cell types, functional inhibition of <italic>miR-21</italic> in cultured GCs using a complementary locked nucleic acid (LNA-21) induced apoptosis.<sup>
<xref ref-type="bibr" rid="bibr27-1933719112442245">27</xref>
</sup> To date, a number of <italic>miR-21</italic> target genes have been implicated in the antiapoptotic effects of<italic> miR-21</italic>, which include <italic>Phosphatase and Tensin Homolog</italic> (<italic>PTEN</italic>), <italic>sprouty 2</italic>, <italic>tropomyocin 1</italic>, and <italic>programmed cell death 4</italic> (<italic>PDCD4</italic>). However, none of these genes have been shown to be <italic>miR-21</italic> targets in GCs,<sup>
<xref ref-type="bibr" rid="bibr27-1933719112442245">27</xref>
</sup> and consistently potential <italic>miR-21</italic> targets, including these 4 genes, were not cloned from EIF2C2-bound mRNAs (<xref ref-type="table" rid="table3-1933719112442245">Table 3</xref>). This is also supported by our data that overexpression and inhibition of <italic>miR-21</italic> in KGN cells had no effect on expression of PTEN protein (data not shown). This result should not be surprising because increasing evidence has recently shown that targets of miRNA are cell specific.<sup>
<xref ref-type="bibr" rid="bibr28-1933719112442245">28</xref>
</sup> Although <italic>miR-21</italic> target gene/genes in GCs have remained elusive, it is noteworthy that functional blockade of <italic>miR-21</italic> in vivo decreased the ovulation rate,<sup>
<xref ref-type="bibr" rid="bibr27-1933719112442245">27</xref>
</sup> which was similar to the effect that the targeted deletion of <italic>Dicer1</italic> had on ovulation rate.<sup>
<xref ref-type="bibr" rid="bibr24-1933719112442245">24</xref>,<xref ref-type="bibr" rid="bibr25-1933719112442245">25</xref>
</sup>
</p>
<p>
<italic>MiR-21</italic> was selectively enriched in EIF2C2-containing RISC in GC cells (accounted for more than 80% of EIF2C2-bound miRNAs in GC lines as shown in <xref ref-type="table" rid="table2-1933719112442245">Table 2</xref>), although an underlying mechanism remains elusive. In flies, it has been reported that the 5′-ends of miRNA sequences loaded into AGO2 (fly homologue of EIF2C2)-containing RISC are more precisely defined than the 5′-ends of the same small RNA sequences in the total small RNA population.<sup>
<xref ref-type="bibr" rid="bibr29-1933719112442245">29</xref>
</sup> It is conceivable that RISC could load individual miRNAs differentially in a seed sequence-dependent manner in GCs. In this study, based on a hypothesis that the <italic>miR-21</italic> target mRNAs should be also enriched in RISC of these cells, we immunoprecipitated and cloned EIF2C2-bound mRNAs. Of the isolated EIF2C2-bound mRNAs, <italic>COL4A1</italic> was the most probable <italic>miR-21</italic> target for the following reasons: (1) <italic>COL4A1</italic> was identified in 2 hits, whereas most of the other candidates were identified in single hit (<xref ref-type="table" rid="table3-1933719112442245">Table 3</xref>) and (2) this gene is predicted to be an <italic>miR-21</italic> target by in silico analysis. Furthermore, we experimentally validated the prediction using the human GC lines with <italic>miR-21</italic> overexpression or inhibition (<xref ref-type="fig" rid="fig5-1933719112442245">Figure 5</xref>). The <italic>COL4A2</italic> was also cloned from EIF2C2-bound mRNAs, although this gene was not predicted in silico to be an <italic>miR-21</italic> target. Thus, it is likely that <italic>miR-21</italic> plays a role in the synthesis of type IV collagen.</p>
<p>Type IV collagens are major components of BM. Follicular BM lies beneath the granulosa layer and plays a role in regulating granulosa cell proliferation and differentiation.<sup>
<xref ref-type="bibr" rid="bibr30-1933719112442245">30</xref>
<xref ref-type="bibr" rid="bibr31-1933719112442245"/>–<xref ref-type="bibr" rid="bibr32-1933719112442245">32</xref>
</sup> It has been also demonstrated that type IV collagen, which is produced around luteinizing human granulosa cells during ovulation, attenuates progesteron production, indicating that type IV collagen could be a new parameter and/or regulator of granulosa cell luteinization.<sup>
<xref ref-type="bibr" rid="bibr33-1933719112442245">33</xref>
</sup> In addition, the follicular BM excludes capillaries and nerve processes from the granulosa until ovulation, at which point the BM is degraded.<sup>
<xref ref-type="bibr" rid="bibr32-1933719112442245">32</xref>
</sup> Although type IV collagen is composed of 6 distinct alpha chains, α1 (IV) through α6 (IV), corresponding to <italic>COL4A1</italic> through <italic>COL4A6</italic> gene product, (α1 (IV)<sub>2</sub> α2(IV)) is the most common form. In addition to follicular BM, novel types of BM-like matrix (designated focimatrix and Call-Exner bodies) were found in the granulosa of bovine follicles, both of which contained α1 (IV) and α2 (IV) chains.<sup>
<xref ref-type="bibr" rid="bibr32-1933719112442245">32</xref>
</sup> Although the physiological roles of these structures are not well known, it has been shown that focimatrix, as well as follicular BM, is degraded at ovulation.<sup>
<xref ref-type="bibr" rid="bibr32-1933719112442245">32</xref>
</sup> Thus, taken together with our results, it is possible that <italic>miR-21</italic> is involved in the type IV collagen-mediated events associated with ovulation and luteinization of the ovarian follicle. However, considering that the effect of <italic>miR-21</italic> on <italic>COL4A1</italic> regulation appears rather weak in this study, its physiological relevance is currently unclear. Thus, further investigation should be necessary to clarify this issue.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Takuji Kosuge and Yoshimi Hinohara for providing technical assistance. Sequencing and the following bioinformatics analyses were supported by the Takara-Bio Dragon Genomics Center (Yokkaichi, Japan).</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn1-1933719112442245">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-1933719112442245">
<label>Funding</label>
<p>The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported in part by Grants-in-Aids and “Research Core” Project for Private University: Matching Fund Subsidy from the Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science, Japan.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1933719112442245">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartel</surname>
<given-names>DP</given-names>
</name>
</person-group>. <article-title>MicroRNAs: target recognition and regulatory functions</article-title>. <source>Cell</source>. <year>2009</year>;<volume>136</volume>(<issue>2</issue>):<fpage>215</fpage>–<lpage>233</lpage>.</citation>
</ref>
<ref id="bibr2-1933719112442245">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Belasco</surname>
<given-names>JG</given-names>
</name>
</person-group>. <article-title>Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs</article-title>. <source>Mol Cell</source>. <year>2008</year>;<volume>29</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr3-1933719112442245">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caron</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Lafontaine</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Massé</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Small RNA-mediated regulation at the level of transcript stability</article-title>. <source>RNA Biol</source>. <year>2010</year>;<volume>7</volume>(<issue>2</issue>):<fpage>140</fpage>–<lpage>144</lpage>.</citation>
</ref>
<ref id="bibr4-1933719112442245">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ingolia</surname>
<given-names>NT</given-names>
</name>
<name>
<surname>Weissman</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Bartel</surname>
<given-names>DP</given-names>
</name>
</person-group>. <article-title>Mammalian microRNAs predominantly act to decrease target mRNA levels</article-title>. <source>Nature</source>. <year>2010</year>;<volume>466</volume>(<issue>7308</issue>):<fpage>835</fpage>–<lpage>840</lpage>.</citation>
</ref>
<ref id="bibr5-1933719112442245">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huntzinger</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Izaurralde</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>Gene silencing by microRNAs: contributions of translational repression and mRNA decay</article-title>. <source>Nat Rev Genet</source>. <year>2010</year>;<volume>12</volume>(<issue>2</issue>):<fpage>99</fpage>–<lpage>110</lpage>.</citation>
</ref>
<ref id="bibr6-1933719112442245">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Rooij</surname>
<given-names>E</given-names>
</name>
</person-group>. <article-title>The art of microRNA research</article-title>. <source>Circ Res</source>. <year>2011</year>;<volume>108</volume>(<issue>2</issue>):<fpage>219</fpage>–<lpage>234</lpage>.</citation>
</ref>
<ref id="bibr7-1933719112442245">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farazi</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Spitzer</surname>
<given-names>JI</given-names>
</name>
<name>
<surname>Morozov</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tuschl</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>. miRNAs in human cancer</article-title>. <source>J Pathol</source>. <year>2011</year>;<volume>223</volume>(<issue>2</issue>):<fpage>102</fpage>–<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr8-1933719112442245">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>McManus</surname>
<given-names>MT</given-names>
</name>
</person-group>. <article-title>Analysis of microRNA knockouts in mice</article-title>. <source>Hum Mol Genet</source>. <year>2010</year>;<volume>19</volume>(<issue>R2</issue>):<fpage>R169</fpage>–<lpage>R175</lpage>.</citation>
</ref>
<ref id="bibr9-1933719112442245">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tajima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Orisaka</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yata</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hosokawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kotsuji</surname>
<given-names>F</given-names>
</name>
</person-group>. <article-title>Role of granulosa and theca cell interactions in ovarian follicular maturation</article-title>. <source>Microsc Res Tech</source>. <year>2006</year>;<volume>69</volume>(<issue>6</issue>):<fpage>450</fpage>–<lpage>458</lpage>.</citation>
</ref>
<ref id="bibr10-1933719112442245">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murchison</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Xuan</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group> <article-title>Critical roles for Dicer in the female germline</article-title>. <source>Genes Dev</source>. <year>2007</year>;<volume>21</volume>(<issue>6</issue>):<fpage>682</fpage>–<lpage>693</lpage>.</citation>
</ref>
<ref id="bibr11-1933719112442245">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kaneda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>O’Carroll</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Maternal microRNAs are essential for mouse zygotic development</article-title>. <source>Genes Dev</source>. <year>2007</year>;<volume>21</volume>(<issue>6</issue>):<fpage>644</fpage>–<lpage>648</lpage>.</citation>
</ref>
<ref id="bibr12-1933719112442245">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sirotkin</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Ovcharenko</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Grossmann</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lauková</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mlyncek</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Identification of microRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen</article-title>. <source>J Cell Physiol</source>. <year>2009</year>;<volume>219</volume>(<issue>2</issue>):<fpage>415</fpage>–<lpage>420</lpage>.</citation>
</ref>
<ref id="bibr13-1933719112442245">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sirotkin</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Lauková</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ovcharenko</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Brenaut</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mlyncek</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Identification of microRNAs controlling human ovarian cell proliferation and apoptosis</article-title>. <source>J Cell Physiol</source>. <year>2010</year>;<volume>223</volume>(<issue>1</issue>):<fpage>49</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr14-1933719112442245">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lian</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4</article-title>. <source>Mol Endocrinol</source>. <year>2010</year>;<volume>24</volume>(<issue>3</issue>):<fpage>540</fpage>–<lpage>551</lpage>.</citation>
</ref>
<ref id="bibr15-1933719112442245">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perron</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Provost</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Protein components of the microRNA pathway and human diseases</article-title>. <source>Methods Mol Biol</source>. <year>2009</year>;<volume>487</volume>:<fpage>369</fpage>–<lpage>385</lpage>.</citation>
</ref>
<ref id="bibr16-1933719112442245">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yanase</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Oba</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ichino</surname>
<given-names>I.</given-names>
</name>
</person-group> <article-title>Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor</article-title>. <source>Endocrinology</source>. <year>2001</year>;<volume>142</volume>(<issue>1</issue>):<fpage>437</fpage>–<lpage>445</lpage>.</citation>
</ref>
<ref id="bibr17-1933719112442245">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okamura</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Katabuchi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ohba</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>What we have learned from isolated cells from human ovary?</article-title> <source>Mol Cell Endocrinol</source>. <year>2003</year>;<volume>202</volume>(<issue>1-2</issue>):<fpage>37</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr18-1933719112442245">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kondo</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kiguchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Okamura</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Establishment and characterization of a human ovarian granulosa tumor cell line (HSOGT)</article-title>. <source>Hum Cell</source>. <year>2003</year>;<volume>16</volume>(<issue>3</issue>):<fpage>123</fpage>–<lpage>129</lpage>.</citation>
</ref>
<ref id="bibr19-1933719112442245">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mishima</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Takizawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>SS</given-names>
</name>
<etal/>
</person-group> <article-title>MicroRNA (miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary</article-title>. <source>Reproduction</source>. <year>2008</year>;<volume>136</volume>(<issue>6</issue>):<fpage>811</fpage>–<lpage>822</lpage>.</citation>
</ref>
<ref id="bibr20-1933719112442245">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kristiansen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>SOAP: short oligonucleotide alignment program</article-title>. <source>Bioinformatics</source>. <year>2008</year>;<volume>24</volume>(<issue>5</issue>):<fpage>713</fpage>–<lpage>714</lpage>.</citation>
</ref>
<ref id="bibr21-1933719112442245">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>S-S</given-names>
</name>
<name>
<surname>Ishibashi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group> <article-title>Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes</article-title>. <source>Biol Reprod</source>. <year>2009</year>;<volume>81</volume>(<issue>4</issue>):<fpage>717</fpage>–<lpage>729</lpage>.</citation>
</ref>
<ref id="bibr22-1933719112442245">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Landgraf</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rusu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sheridan</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>A mammalian microRNA expression atlas based on small RNA library sequencing</article-title>. <source>Cell</source>. <year>2007</year>;<volume>129</volume>(<issue>7</issue>):<fpage>1401</fpage>–<lpage>1414</lpage>.</citation>
</ref>
<ref id="bibr23-1933719112442245">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Behringer</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Woodruff</surname>
<given-names>TK</given-names>
</name>
</person-group>. <article-title>The regulatory role of Dicer in folliculogenesis in mice</article-title>. <source>Mol Cell Endocrinol</source>. <year>2010</year>;<volume>315</volume>(<issue>1-2</issue>):<fpage>63</fpage>–<lpage>73</lpage>.</citation>
</ref>
<ref id="bibr24-1933719112442245">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Luense</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>McGinnis</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Nothnick</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Christenson</surname>
<given-names>LK</given-names>
</name>
</person-group>. <article-title>Dicer1 is essential for female fertility and normal development of the female reproductive system</article-title>. <source>Endocrinology</source>. <year>2008</year>;<volume>149</volume>(<issue>12</issue>):<fpage>6207</fpage>–<lpage>6212</lpage>.</citation>
</ref>
<ref id="bibr25-1933719112442245">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagaraja</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Andreu-Vieyra</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Franco</surname>
<given-names>HL</given-names>
</name>
<etal/>
</person-group> <article-title>Deletion of Dicer in somatic cells of the female reproductive tract causes sterility</article-title>. <source>Mol Endocrinol</source>. <year>2008</year>;<volume>22</volume>(<issue>10</issue>):<fpage>2336</fpage>–<lpage>2352</lpage>.</citation>
</ref>
<ref id="bibr26-1933719112442245">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Behringer</surname>
<given-names>RR</given-names>
</name>
</person-group>. <article-title>Dicer is required for female reproductive tract development and fertility in the mouse</article-title>. <source>Mol Reprod Dev</source>. <year>2009</year>;<volume>76</volume>(<issue>7</issue>):<fpage>678</fpage>–<lpage>688</lpage>.</citation>
</ref>
<ref id="bibr27-1933719112442245">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carletti</surname>
<given-names>MZ</given-names>
</name>
<name>
<surname>Fiedler</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Christenson</surname>
<given-names>LK</given-names>
</name>
</person-group>. <article-title>MicroRNA 21 blocks apoptosis in mouse periovulatory granulosa cells</article-title>. <source>Biol Reprod</source>. <year>2010</year>;<volume>83</volume>(<issue>2</issue>):<fpage>286</fpage>–<lpage>295</lpage>.</citation>
</ref>
<ref id="bibr28-1933719112442245">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sood</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Krek</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zavolan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Macino</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rajewsky</surname>
<given-names>N</given-names>
</name>
</person-group>. <article-title>Cell-type-specific signatures of microRNAs on target mRNA expression</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2006</year>;<volume>103</volume>(<issue>8</issue>):<fpage>2746</fpage>–<lpage>2751</lpage>.</citation>
</ref>
<ref id="bibr29-1933719112442245">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seitz</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ghildiyal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zamore</surname>
<given-names>PD</given-names>
</name>
</person-group>. <article-title>Argonaute loading improves the 5′ precision of both microRNAs and their miRNA* strands in flies</article-title>. <source>Curr Biol</source>. <year>2008</year>;<volume>18</volume>(<issue>2</issue>):<fpage>147</fpage>–<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr30-1933719112442245">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amsterdam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rotmensch</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Furman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Venter</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Vlodavsky</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Synergistic effect of human chorionic gonadotropin and extracellular matrix on in vitro differentiation of human granulosa cells: progesterone production and gap junction formation</article-title>. <source>Endocrinology</source>. <year>1989</year>;<volume>124</volume>(<issue>4</issue>):<fpage>1956</fpage>–<lpage>1964</lpage>.</citation>
</ref>
<ref id="bibr31-1933719112442245">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richardson</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Dunsford</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Inman</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Masson</surname>
<given-names>GM</given-names>
</name>
</person-group>. <article-title>Cultured human granulosa cells as a model for corpus luteum function: relative roles of gonadotrophin and low density lipoprotein studied under defined culture conditions</article-title>. <source>Hum Reprod</source>. <year>1992</year>;<volume>7</volume>(1):<fpage>12</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr32-1933719112442245">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irving-Rodgers</surname>
<given-names>HF</given-names>
</name>
<name>
<surname>Rodgers</surname>
<given-names>RJ</given-names>
</name>
</person-group>. <article-title>Extracellular matrix of the developing ovarian follicle</article-title>. <source>Semin Reprod Med</source>. <year>2006</year>;<volume>24</volume>(<issue>4</issue>):<fpage>195</fpage>–<lpage>203</lpage>.</citation>
</ref>
<ref id="bibr33-1933719112442245">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fujiwara</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Honda</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>Human granulosa cells express integrin alpha2 and collagen type IV: possible involvement of collagen type IV in granulosa cell luteinization</article-title>. <source>Mol Hum Reprod</source>. <year>1999</year>;<volume>5</volume>(<issue>7</issue>):<fpage>607</fpage>–<lpage>617</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>